Saturday | 6 December, 2008
Australian Biotechnology News

Stories about: John Curtin School of Medical Research

  • +

    The mammalian genome and phenome 07/04/2005 11:50:19

    Chris Goodnow talks about defining the mammalian phenome and how this may pan out in the future.
  • +

    Contagious success 22/03/2005 16:24:01

    Australians lead the way in vaccine research for malaria and other infectious diseases, writes Michael Good.
  • +

    View from the future 22/03/2005 14:10:38

    Simon Easteal and Pythia Demonsthenes step back from 2050 to brief us on a century of healthcare.
  • +

    Adjuvants: the players 17/02/2005 14:45:43

    Several Australian companies are trialling new 'natural' and synthetic adjuvants that combine potent immuno-stimulatory activity with low toxicity. Australia's biggest biotech, Melbourne's CSL (ASX:CSL), is boosting its experimental vaccines with its Iscomatrix adjuvant system, a phospholipid-cholesterol formulation containing a purified saponin extract from the bark of the South American tree Quillaja saponaria.
  • +

    Australian professor to chair WHO committee 10/12/2004 10:09:28

    Prof Judith Whitworth - a specialist in hypertension, and current director of the John Curtin School of Medical Research - has been appointed for a three-year term as chair of the World Health Organisation (WHO) Advisory Committee on Health Research.
  • +

    Biotron publishes SARS research 11/11/2004 14:53:59

    Canberra biotech company Biotron (ASX:BIT) has published the results of its SARS virus ion channel research in the journal Virology.
  • +

    Up to his own devices: Alan Finkel on life after Axon 26/07/2004 15:27:23

    Ask Alan Finkel what he would do differently if he started another company, and he’s quick to reply. “I wouldn’t start another company overseas,” he says.
  • +

    News: Pox researchers point to bioterrorism solutions 21/06/2004 11:39:55

    The way certain cytokines regulate the immune response to mousepox has potential to help with poxvirus infections, including smallpox, according to new research at the ANU.
  • +

    Australia's capital territory set to ban GM crops 02/03/2004 15:05:51

    The Australian Capital Territory, home to CSIRO's Plant Industry division, looks set to join the southern mainland states and Tasmania in imposing a moratorium on the environmental release of genetically modified crops.
  • +

    Vaccine firm names new CEO 06/02/2004 14:54:33

    Canberra vaccine developer Vaxine has appointed Ted Stapinski, a 20-year veteran of Australia's space industry, as its new CEO.
  • +

    Research, biobusiness honoured in Australia Day awards 27/01/2004 13:59:07

    Last week, ResMed's California-based chairman and CEO Dr Peter Farrell was in his usual stirring form at a Melbourne speech, referring to Australia as "Botswana" and the nation's flag as a "dog's breakfast". But perhaps he was just getting it all out of his system one last time -- on Monday, Farrell was named a Member of the Order of Australia (AM), one of the top gongs in the annual Australia Day honours
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links